Diabetic retinopathy in pregnancy: a review

Clinical and Experimental Ophthalmology

Volumn 44, Issue 4, 2016, Pages 321-334

  Morrison, Julie L ^a,b   Hodgson, Lauren A B ^a,b   Lim, Lyndell L ^a,b   Al Qureshi, Salmaan ^a,b  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

diabetic retinopathy; pre existing diabetes; pregnancy; prevalence

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; CORTICOSTEROID; PREDNISOLONE; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN ANTIBODY;

AUSTRALIA; BLINDNESS; CLEFT LIP; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; EMBRYOTOXICITY; ETHNICITY; EYE EXAMINATION; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; LOW BIRTH WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPHTHALMOSCOPY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY DISORDER; PRENATAL CARE; PREVALENCE; PROLIFERATIVE DIABETIC RETINOPATHY; PUERPERIUM; RETINA EXAMINATION; RETINA FLUORESCEIN ANGIOGRAPHY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SLIT LAMP; SYSTOLIC BLOOD PRESSURE; TERATOGENICITY; VISUAL ACUITY;

EID: 84974784592     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12760     Document Type: Review

References (73)

1. Dunstan DW, Zimmet PZ, Welborn TA, de Courten MP, Cameron AJ, Sicree RA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care 2002 May 1; 25:829–34.
2. Lawrence JM, Contreras R, Chen W, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care 2008 May 1; 31:899–904.
3. Australian Institute of Health and Welfare. Diabetes in Pregnancy: Its Impact on Australian Women and their Babies, Diabetes Series No. 14. Canberra: AIHW, 2010.
4. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. In: US Department of Health and Human Services. Atlanta, GA,: Centers for Disease Control and Prevention, 2011.
5. Diabetes Control Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The diabetes control and complications trial research group. Diabetes Care 2000; 23 (8): 1084–91.
6. Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990; 13 (1): 34–40.
7. International Diabetes Federation. IDF diabetes atlas, 6th edn Brussels, Belgium International Diabetes Federation 2013. Available from: http://www.idf.org/diabetesatlas
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008 January 1; 31(Supplement 1): S55–S60.
9. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007 July 1; 30 (Supplement 2):S112–S9.
10. American Academy of Ophthalmology Retina/Vitreous Panel. Preferred Practice Pattern®Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology, 2014.
11. Hilder L, Zhichao Z, Parker M, Jahan S, Chambers GM. Australia's Mothers and Babies 2012, Perinatal Statistics Series No. 30. Cat. No. PER 69. Canberra: AIHW, editor, 2014.
12. Confidential Enquiry into Maternal and Child Health. Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002–03. England, Wales and Northern Ireland. London: CEMACH, 2005.
13. Omori Y, Minei S, Testuo T, Nemoto K, Shimizu M, Sanaka M. Current status of pregnancy in diabetic women. A comparison of pregnancy in IDDM and NIDDM mothers. Diabetes Res Clin Pract 1994; 24 (Supplement): S273–S8.
14. Harris SB, Caulfield LE, Sugamori ME, Whalen EA, Henning B. The epidemiology of diabetes in pregnant native Canadians: a risk profile. Diabetes Care 1997; 20: 1422–5.
15. Rasmussen KL, Laugesen CS, Ringholm L, Vestgaard M, Damm P, Mathiesen ER. Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes. Diabetologia 2010; 53: 1076–83. English.
16. Axer-Siegel R, Hod M, Fink-Cohen S, et al. Diabetic retinopathy during pregnancy. Ophthalmology 1996; 103: 1815–9.
17. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy: the diabetes in early pregnancy study. Diabetes Care 1995; 18: 631–7.
18. Dibble CM, Kochenour NK, Worley RJ, Tyler FH, Swartz M. Effect of pregnancy on diabetic retinopathy. Obstet Gynecol 1982; 59: 699–704.
19. Moloney JBM, Drury MI. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 1982; 93: 745–56.
20. Phelps RL, Sakol P, Metzger BE, Jampol LM, Freinkel N. Changes in diabetic retinopathy during pregnancy correlations with regulation of hyperglycemia. Arch Ophthalmol 1986; 104: 1806–10.
21. Rahman W, Rahman FZ, Yassin S, Al-Suleiman SA, Rahman J. Progression of retinopathy during pregnancy in type 1 diabetes mellitus. Clin Experiment Ophthalmol 2007; 35: 231–6.
22. Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in type 1 diabetes. Diabet Med 2001; 18 (7): 573–7.
23. Vestgaard M, Ringholm L, Laugesen CS, Rasmussen KL, Damm P, Mathiesen ER. Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes. Diabet Med 2010; 27 (4): 431–5.
24. Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 2008; 31 (5): 1060–79.
25. Soubrane G, Canivet J, Coscas G. Influence of pregnancy on the evolution of background retinopathy. Int Ophthalmol 1985; 8 (4): 249–55.
26. Hellstedt T, Kaaja R, Teramo K, Immonen U. The effect of pregnancy on mild diabetic retinopathy. Graefe's Arch Clin Exp Ophthalmol 1997; 235 (7): 437–41. English.
27. Egan AM, McVicker L, Heerey A, Carmody L, Harney F, Dunne FP. Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes. J Diabetes Res 2015; 2015: 310239. PubMed PMID: PMC4402566.
28. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992; 166 (4): 1214–8.
29. Lauszus F, Klebe JG, Bek T. Diabetic retinopathy in pregnancy during tight metabolic control. Acta Obstet Gynecol Scand 2000; 79 (5): 367–70.
30. Lövestam-Adrian M, Agardh CD, Åberg A, Agardh E. Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type 1 diabetic patients. Diabet Med 1997; 14 (12): 1059–65.
31. The Diabetes Control Complications Trial Research Group. Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol 1998; 116 (7): 874–86.
32. American Diabetes Association. 12. Management of diabetes in pregnancy. Diabetes Care 2015; 38 (Supplement 1): S77–S9.
33. Ng SK, Wood JPM, Chidlow G, et al. Cancer-like metabolism of the mammalian retina. Clin Experiment Ophthalmol 2015; 43 (4): 367–76.
34. Aiello LP, Group ftDER. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014 January 1; 37(1): 17–23.
35. Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376 (9741): 631–44.
36. Hemachandra A, Ellis D, Lloyd CE, Orchard TJ. The influence of pregnancy on IDDM complications. Diabetes Care 1995 July 1; 18(7): 950–4.
37. Klein BEK, Klein R. Gravidity and diabetic retinopathy. Am J Epidemiol 1984 April 1; 119(4): 564–9.
38. International Council of Ophthalmology. ICO guidelines for diabetic eye care. ICO; 2014.
39. Scottish Intercollegiate Guidelines Network (SIGN). Management of Diabetes. A National Clinical Guideline. Edinburgh: SIGN, 2010.
40. National Health and Medical Research Council. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines, Stage 2 Consultation, Early 2008 – end June 2009.
41. National Health and Medical Research Council. Guidelines for the Management of Diabetic Retinopathy. Canberra: NHMRC, 2008.
42. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2013; 37 (suppl 1): S1–S212.
43. New Zealand Ministry of Health. National Diabetes Retinal Screening Grading System and Referral Guidelines 2006. Wellington, New Zealand: Ministry of Health, 2008.
44. National Collaborating Centre for Women's and Children's Health. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. Commissioned by the National Institute for Health and Care Excellence; 2015.
45. Ministry of Health. Clinical Practice Guidelines: Screening of Diabetic Retinopathy. Putrajaya, Malaysia: Ministry of Health, 2011.
46. McElduff A, Ross GP, Lagström JA, et al. Pregestational diabetes and pregnancy: an Australian experience. Diabetes Care 2005; 28 (5): 1260–1.
47. Cheung NW, McElduff A, Ross GP. Type 2 diabetes in pregnancy: a wolf in sheep's clothing. Aust N Z J Obstet Gynaecol 2005; 45 (6): 479–83.
48. Macfarlane DP, O'Sullivan EP, Dorman S, et al. The utility of retinal screening in gestational diabetes. Diabet Med 2013; 30 (8): 1009–10.
49. Arun CS, Taylor R. Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes. Diabetologia 2008; 51 (6): 1041–5. English.
50. The Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions Complications Research Group. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes 2015; 64(2): 631–42.
51. Gordin D, Kaaja R, Forsblom C, Hiilesmaa V, Teramo K, Groop P-H. Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life. Acta Diabetol 2013 2013/10/01; 50(5): 781–7. English.
52. Halperin LS, Olk RJ, Soubrane G, Coscas G. Safety of fluorescein angiography during pregnancy. Am J Ophthalmol 1990; 109 (5): 563–6.
53. Novartis Pharmaceuticals Australia Pty Limited. Product information fluorescite* (fluorescein injection) 10% 2015. Available from: https://www.tga.gov.au/artg/artg-id-124267
54. Chan WC, Lim LT, Quinn MJ, Knox FA, McCance D, Best RM. Management and outcome of sight-threatening diabetic retinopathy in pregnancy. Eye 2004; 18 (8): 826–32.
55. Sinclair SH, Nesler C, Foxman B, Nichols CW, Gabbe S. Macular edema and pregnancy in insulin-dependent diabetes. Am J Ophthalmol 1984; 97 (2): 154–67.
56. Hampshire R, Wharton H, Leigh R, Wright A, Dodson P. Screening for diabetic retinopathy in pregnancy using photographic review clinics. Diabet Med 2013; 30 (4): 475–7.
57. Ohrt V. The influence of pregnancy on diabetic retinoapthy with special regard to the reversible changes shown in 100 pregnancies. Acta Ophthalmol 1984; 62 (4): 603–16.
58. Sunness JS. The pregnant woman's eye. Surv Ophthalmol 1988; 32 (4): 219–38.
59. Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol 2009; 147 (1): 11–21.e1.
60. The Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: early treatment diabetic retinopathy study report no. 4. Int Ophthalmol Clin 1987; 27 (4): 265–72.
61. Bayer Australia Ltd. Product information: eylea (aflibercept). 2015.
62. Novartis Pharmaceuticals Australia Pty Limited. Product information: Lucentis (Ranibizumab). 2015.
63. Genentech Inc. Bevacizumab (Avastin) solution for intravenous infusion. Highlights of Prescribing Information. San Fransisco, CA, 2015.
64. Tarantola RM, Folk JC, Boldt HC, Mahajan VB. Intravitreal Bevacizumab during pregnancy. Retina 2010; 30 (9): 1405–11.
65. Petrou P, Georgalas I, Giavaras G, Anastasiou E, Ntana Z, Petrou C. Early loss of pregnancy after intravitreal bevacizumab injection. Acta Ophthalmol 2010; 88 (4): e136.
66. Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema. Ophthalmology 2014; 121 (5): 1045–53.
67. Aspen Pharmacare Australia Pty Ltd. Prednisolone product information 2010 [8/10/2015]. Available from: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-06870-3.
68. Alcon Laboratories. Triesence prescribing information 2007 [27/09/2015]. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2007/022223,022048lbl.pdf.
69. Fazelat A, Lashkari K. Off-label use of intravitreal triamcinolone acetonide for diabetic macular edema in a pregnant patient. Clin Ophthalmol (Auckland, NZ) 2011; 5: 439–41. PubMed PMID: PMC3090296.
70. Horvat M, Maclean H, Goldberg L, Crock GW. Diabetic retinopathy in pregnancy: a 12-year prospective survey. Br J Ophthalmol 1980 June 1; 64(6): 398–403.
71. Fred Hollows Foundation New Zealand. Diabetes retinal screening, grading and management guidelines for use in Pacific Island Nations. Auckland, New Zealand, 2010.
72. IDF Clinical Guidelines Task Force. Global Guideline on Pregnancy and Diabetes. Brussels: International Diabetes Federation, 2009.
73. Vision 2020 Program of the IAPB for Latin America. Clinical practice guide for diabetic retinopathy for Latin America. Mexico, 2011.